Central Clinical Hospital #1

Moscow 125367

0 studies enrolling now · 2 studies all time

What they study most

Intermittent Claudication, Non Small Cell Lung Cancer, Peripheral Vascular Diseases

Studies at this site

• A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Completed
• PROVIDENCE-1: Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients — Status unconfirmed